Addison Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
18,026
-27
| -0.1% | -$2.11K | 0.35% | 61 |
|
|
2025
Q1 | $1.31M | Sell |
18,053
-48
| -0.3% | -$3.48K | 0.36% | 56 |
|
|
2024
Q4 | $1.34M | Buy |
18,101
+63
| +0.3% | +$4.66K | 0.37% | 57 |
|
|
2024
Q3 | $1.19M | Buy |
18,038
+16,261
| +915% | +$1.07M | 0.33% | 61 |
|
|
2024
Q2 | $164K | Buy |
1,777
+19
| +1% | +$1.76K | 0.05% | 227 |
|
|
2024
Q1 | $168K | Buy |
1,758
+98
| +6% | +$9.37K | 0.06% | 215 |
|
|
2023
Q4 | $127K | Buy |
1,660
+104
| +7% | +$7.93K | 0.05% | 249 |
|
|
2023
Q3 | $108K | Sell |
1,556
-31
| -2% | -$2.15K | 0.05% | 242 |
|
|
2023
Q2 | $150K | Buy |
1,587
+91
| +6% | +$8.58K | 0.07% | 190 |
|
|
2023
Q1 | $124K | Buy |
1,496
+1,092
| +270% | +$90.3K | 0.07% | 194 |
|
|
2022
Q4 | $30.1K | Buy |
404
+354
| +708% | +$26.4K | 0.02% | 334 |
|
|
2022
Q3 | $4K | Sell |
50
-634
| -93% | -$50.7K | ﹤0.01% | 513 |
|
|
2022
Q2 | $65K | Sell |
684
-84
| -11% | -$7.98K | 0.04% | 234 |
|
|
2022
Q1 | $90K | Buy |
768
+747
| +3,557% | +$87.5K | 0.05% | 216 |
|
|
2021
Q4 | $3K | Buy |
+21
| New | +$3K | ﹤0.01% | 492 |
|